Menu

Travelers to West Africa Banned from Conference

Louisiana state health officials ask anyone who has visited Liberia, Sierra Leone, or Guinea in the past 21 days to skip next week’s meeting on tropical diseases in New Orleans.

Oct 31, 2014
Jef Akst

FLICKR, ITU PICTURESThe annual meeting of American Society of Tropical Medicine and Hygiene (ASTMH), set to begin in New Orleans on Sunday, will be missing at least some of its planned attendees because Louisiana state health officials are asking that anyone who has traveled to an Ebola-affected region or treated an Ebola patient stay home.

“From a medical perspective, asymptomatic individuals are not at risk of exposing others; however, the State is committed to preventing any unnecessary exposure of Ebola to the general public,” Kathy Kliebert, secretary of Louisiana’s Department of Health and Hospitals, and Kevin Davis, director of the Governor’s Office of Homeland Security and Emergency Preparedness wrote in a letter to registered conference attendees. “In Louisiana, we love to welcome visitors, but we must balance that hospitality with the protection of Louisiana residents and other visitors.”

Tropical diseases expert Piero Olliaro of the World Health Organization (WHO) and the University of Oxford in the U.K. is among the list of those who will be prevented from attending the meeting as a result of the new guidelines. He traveled to Guinea earlier this month in search of sites for upcoming trials of Ebola drugs in development. “I’m very upset. And that’s an understatement,” he told ScienceInsider, which reported that he was scheduled to co-chair a session, give two talks, and present six posters.

Incoming ASTMH President Christopher Plowe of the University of Maryland School of Medicine told ScienceInsider that other WHO representatives, as well as those from US Centers for Disease Control and Prevention (CDC), are also now restricted from attending the conference. “They are quite disappointed,” said Plowe. Ultimately, he added, this decision “puts Americans at higher risk.” Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine in Houston, Texas, agreed: “It’s very unfortunate and could potentially be counterproductive by preventing health care workers from Liberia, Sierra Leone, and Guinea from sharing their experiences and findings at one of the most important tropical disease meetings globally.”

Kliebert and Davis stated in the letter that the decision was made “out of an abundance of caution,” and that restricting travel does “not reflect a lack of appreciation for your service and sacrifice in efforts to treat and end the epidemic.” In response, Tulane University’s Daniel Bausch, who is the organizer of one of two specialized Ebola symposia at the upcoming meeting, told ScienceInsider: “Out of an abundance of caution . . . I’ve come to hate that term. It means it’s not evidence-based, there’s no science to support it, but we’re going to do it anyway.”

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.